XML 44 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation Arrangements
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation Arrangements Share-Based Compensation Arrangements
The 2013 Stock Option and Incentive Plan (the “2013 Plan”) was approved by shareholders on April 23, 2013. The 2013 Plan permits the granting of stock options and other equity incentives to officers, employees, directors and other key persons. Vesting of stock options and share awards may accelerate or may be subject to proportional vesting if there is a change in control, disability, retirement or death (as defined in the 2013 Plan).

The following table presents share-based compensation expense and the related income tax benefits recognized in the Consolidated Statements of Income for stock options, restricted stock units and performance share units:
(Dollars in thousands)
Years ended December 31,202120202019
Share-based compensation expense$3,316 $3,766 $3,124 
Related income tax benefits (1)
$978 $801 $982 
(1)Includes $182 thousand and $248 thousand, respectively, of excess tax benefits recognized upon the settlement of share-based compensation awards in 2021 and 2019. Includes $103 thousand of excess tax expenses recognized upon the settlement of share-based compensation awards in 2020.

As of December 31, 2021, there was $5.1 million of total unrecognized compensation cost related to share-based compensation arrangements, including stock options, restricted stock units and performance share units granted under the Plans.  That cost is expected to be recognized over a weighted average period of 1.9 years.

Stock Options
The exercise price of each stock option may not be less than the fair market value of the Bancorp’s common stock on the date of grant, and options shall have a term of no more than ten years. Stock options are designated as either non-qualified or incentive stock options. In general, the stock option price is payable in cash, by the delivery of shares of common stock already owned by the grantee, or a combination thereof.  With respect to non-qualified stock option grants issued under the 2013 Plan, the exercise may also be accomplished by withholding the exercise price from the number of shares that would otherwise be delivered upon a cash exercise of the option.

Washington Trust uses historical data to estimate stock option exercise and employee departure behavior in the option-pricing model. The expected term of options granted was derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding.  Expected volatility was based on historical volatility of Washington Trust shares.  The risk-free rate for periods within the contractual life of the stock option was based on the U.S. Treasury yield curve in effect at the date of grant.

The following presents the assumptions used in determining the grant date fair value of the stock option awards granted to certain key employees:
202120202019
Options granted53,70081,53061,800
Cliff vesting period (years)333
Expected term (years)6.56.56.5
Expected dividend yield3.80 %3.69 %3.40 %
Weighted average expected volatility31.50 %29.89 %23.05 %
Weighted average risk-free interest rate1.41 %0.46 %1.71 %
Weighted average grant-date fair value$11.10$5.75$7.44
The following table presents a summary of stock options outstanding as of and for the year ended December 31, 2021:
Number of Stock OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value (000’s)
Beginning of period326,245 $42.44 
Granted53,700 54.59 
Exercised(47,365)31.87 
Forfeited or expired(10,440)44.82 
End of period322,140 $45.95 7.17$3,422 
At end of period:
Options exercisable138,690 $48.81 5.03$1,112 
Options expected to vest in future periods183,450 $43.78 8.78$2,310 

The total intrinsic value is the amount by which the fair value of the underlying stock exceeds the exercise price of an option on the exercise date.

The following table presents additional information concerning options outstanding and options exercisable at December 31, 2021:
Options OutstandingOptions Exercisable
Exercise Price RangesNumber of
Shares
Weighted Average
Remaining Life (Years)
Weighted Average
Exercise Price
Number of SharesWeighted Average
Exercise Price
$20.01 to $30.00
2,900 0.47$23.27 2,900 $23.27 
$30.01 to $40.00
104,048 7.1033.25 30,198 35.76 
$40.01 to $50.00
77,306 6.8946.67 21,406 41.49 
$50.01 to $60.00
137,886 7.5255.60 84,186 56.24 
Total322,140 7.17$45.95 138,690 $48.81 

The total intrinsic value of stock options exercised during the years ended December 31, 2021, 2020 and 2019 was $897 thousand, $46 thousand and $580 thousand, respectively.

Restricted Stock Units
In 2021, 2020 and 2019, the Corporation granted to directors and certain key employees 19,185, 27,385 and 26,070 restricted stock units, respectively, with 3-year cliff vesting.

The following table presents a summary of restricted stock units as of and for the year ended December 31, 2021:
Number of SharesWeighted Average Grant Date Fair Value
Beginning of period66,115 $44.80 
Granted19,185 53.00 
Vested(15,543)52.24 
Forfeited(3,472)45.28 
End of period66,285 $45.41 
Performance Share Units
The Corporation granted performance share units to certain key employees providing the opportunity to earn shares of common stock over a 3-year to 5-year performance period. The number of shares vested and earned will be contingent upon the Corporation’s attainment of certain performance measures as detailed in the performance share award agreements.

The following table presents a summary of outstanding performance share unit awards as of December 31, 2021:
Grant Date Fair Value per ShareWeighted Average Current Performance AssumptionExpected Number of Shares
Performance share units awarded in:2021$46.15140%51,156 
202034.22140%65,632 
201952.84118%36,960 
201854.25140%5,824 
Total159,572 

The following table presents a summary of performance share units as of and for the year ended December 31, 2021:
Number of SharesWeighted Average Grant Date Fair Value
Beginning of period156,367 $45.43 
Granted40,975 44.46 
Vested(37,770)54.25 
Forfeited— — 
End of period159,572 $43.09